Skip to main content

Table 4 Serum levels of PAI-1 in HCC patients and controls

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

GenotypeSerum PAI, ng/mL (mean ± SD)p valuea
nHCC patientsnControl
5G/5G1224.75 ± 11.531220.17 ± 11.460.260
4G/4G925.89 ± 11.831122.09 ± 11.950.446
4G/5G2925.93 ± 10.922426.92 ± 9.920.508
Total5025.64 ± 10.914724.06 ± 10.990.480c
p valueb 0.911 0.264 
  1. PAI-1 platelet activating inhibitor-1
  2. aMann-Whitney test
  3. bKruskal-Wallis test
  4. cStudent’s t test